Correlation Between GeneReach Biotechnology and RDC Semiconductor

Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and RDC Semiconductor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and RDC Semiconductor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneReach Biotechnology and RDC Semiconductor Co, you can compare the effects of market volatilities on GeneReach Biotechnology and RDC Semiconductor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of RDC Semiconductor. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and RDC Semiconductor.

Diversification Opportunities for GeneReach Biotechnology and RDC Semiconductor

0.54

Correlation Coefficient

GeneReach Biotechnology  RDC Semiconductor

Very weak diversification

The 3 months correlation between GeneReach and RDC is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and RDC Semiconductor Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RDC Semiconductor and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with RDC Semiconductor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RDC Semiconductor has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and RDC Semiconductor go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and RDC Semiconductor

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to generate 0.46 times more return on investment than RDC Semiconductor. However, GeneReach Biotechnology is 2.15 times less risky than RDC Semiconductor. It trades about -0.06 of its potential returns per unit of risk. RDC Semiconductor Co is currently generating about -0.05 per unit of risk. If you would invest  3,140  in GeneReach Biotechnology on September 30, 2024 and sell it today you would lose (200.00) from holding GeneReach Biotechnology or give up 6.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

GeneReach Biotechnology  vs.  RDC Semiconductor Co

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneReach Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

RDC Semiconductor

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RDC Semiconductor Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with GeneReach Biotechnology and RDC Semiconductor

The main advantage of trading using opposite GeneReach Biotechnology and RDC Semiconductor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, RDC Semiconductor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RDC Semiconductor will offset losses from the drop in RDC Semiconductor's long position.

The idea behind GeneReach Biotechnology and RDC Semiconductor Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..